Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | RAC-alpha serine/threonine-protein kinase | ||
Ligand | BDBM50528425 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1904982 (CHEMBL4407340) | ||
IC50 | 9.3±n/a nM | ||
Citation | Dong, X; Zhan, W; Zhao, M; Che, J; Dai, X; Wu, Y; Xu, L; Zhou, Y; Zhao, Y; Tian, T; Cheng, G; Jin, Z; Li, J; Shao, Y; He, Q; Yang, B; Weng, Q; Hu, Y Discovery of 3,4,6-Trisubstituted Piperidine Derivatives as Orally Active, Low hERG Blocking Akt Inhibitors via Conformational Restriction and Structure-Based Design. J Med Chem62:7264-7288 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
RAC-alpha serine/threonine-protein kinase | |||
Name: | RAC-alpha serine/threonine-protein kinase | ||
Synonyms: | AKT phosphorylation (p-AKT) | AKT1 | AKT1/PPP1CA | AKT1_HUMAN | C-AKT | PKB | PKB alpha | Protein kinase Akt-1 | Protein kinase B | Protein kinase B (AKT1) | Protein kinase B (Akt 1) | Protein kinase B (Akt) | Protein kinase B alpha | Protein kinase B alpha (AKT1) | Proto-oncogene Akt (Akt1) | Proto-oncogene c-Akt (AKT) | Proto-oncogene c-Akt (AKT1) | RAC | RAC-PK-alpha | RAC-alpha serine/threonine-protein kinase (AKT) | RAC-alpha serine/threonine-protein kinase (AKT1) | RAC-alpha serine/threonine-protein kinase (pAKT) | ||
Type: | Enzyme | ||
Mol. Mass.: | 55681.25 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P31749 | ||
Residue: | 480 | ||
Sequence: |
| ||
BDBM50528425 | |||
n/a | |||
Name | BDBM50528425 | ||
Synonyms: | CHEMBL4591854 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H25Cl2F3N4O8 | ||
Mol. Mass. | 637.389 | ||
SMILES | O[C@H]([C@@H](O)C(O)=O)C(O)=O.Cn1ncc(Cl)c1-c1cc(oc1Cl)C(=O)N[C@@H]1CNCC[C@H]1c1ccc(cc1)C(F)(F)F |r,wU:26.26,wD:1.0,2.2,31.33,(70.18,-38.02,;70.18,-39.55,;71.5,-40.31,;71.5,-41.84,;72.82,-39.55,;74.14,-40.31,;72.82,-38.02,;68.86,-40.31,;67.54,-39.55,;68.86,-41.84,;53.11,-37.38,;52.78,-38.88,;51.37,-39.51,;51.53,-41.04,;53.04,-41.36,;53.66,-42.77,;53.81,-40.03,;55.34,-39.87,;56.37,-41.02,;57.77,-40.4,;57.62,-38.87,;56.12,-38.54,;55.49,-37.13,;59.11,-41.17,;59.1,-42.71,;60.44,-40.41,;61.77,-41.18,;61.77,-42.71,;63.1,-43.49,;64.44,-42.72,;64.44,-41.18,;63.11,-40.41,;63.12,-38.88,;61.78,-38.11,;61.78,-36.56,;63.11,-35.79,;64.45,-36.56,;64.45,-38.11,;63.11,-34.25,;64.44,-33.48,;61.77,-33.49,;63.09,-32.71,)| | ||
Structure |